Birchview Capital, LP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 139 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2022$14,000
-93.8%
20,000
-80.0%
0.01%
-93.2%
Q4 2021$226,000
-21.5%
100,0000.0%0.15%
-25.5%
Q3 2021$288,000
-24.0%
100,0000.0%0.20%
-13.7%
Q2 2021$379,000100,0000.23%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders